Resultados de la búsqueda 1311-1320 of 15219 for Pityriasis rosea

  1. Hematología - Ensayos clínicos

    Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone, work in different ways to stop the growth of cancer ...

  2. Ensayos clínicos - Neurocirugía

    The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid (CSF) leak in ...

  3. Oncología (médica) - Ensayos clínicos

    The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are ...

  4. Mayo Clinic

    Leslie Cooper, M.D., Cardiología de Mayo Clinic: Las arterias hacia su corazón volvieron a estrecharse luego de que le colocaran los estents. En su caso, se ...

  5. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either ...

  7. Neurocirugía - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...

  8. Obstetricia y Ginecología - Ensayos clínicos

    The purpose of this study is to collect paired maternal and umbilical cord blood samples that can be processed for various traits in the blood, ...

  9. Enfermedades alérgicas - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla., Rochester, Minn. The purpose of this study is to evaluate the rate of compliance for having an emergency epinephrine autoinjector readily ...

  10. Hematología - Ensayos clínicos

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.